Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest & Investment Income came in at $219.0 million in Q2 2026, down 15.77% year-over-year from $260.0 million in Q2 2025, and down 4.37% quarter-over-quarter from $229.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest & Investment Income across 18 years of filings, most recently posting $219.0 million for Q2 2026.

  • In Q2 2026, Interest & Investment Income fell 15.77% year-over-year to $219.0 million; the TTM figure through Jun 2026 stood at $912.0 million (down 21.72% YoY), while the FY2025 annual figure was $1.1 billion, down 20.72% from the prior year.
  • Interest & Investment Income came in at $219.0 million for Q2 2026 at Johnson & Johnson, down from $229.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $450.0 million in Q1 2023 to a low of $22.0 million in Q2 2022.
  • Average Interest & Investment Income over 5 years is $265.7 million, with a median of $270.5 million recorded in 2024.
  • Year-over-year, Interest & Investment Income soared 1053.85% in 2022 and slumped 34.18% in 2025.
  • Over 5 years, Interest & Investment Income stood at $150.0 million in 2022, then soared by 142.0% to $363.0 million in 2023, then dropped by 22.59% to $281.0 million in 2024, then slipped by 15.66% to $237.0 million in 2025, then slipped by 7.59% to $219.0 million in 2026.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were $219.0 million in Q2 2026, $229.0 million in Q1 2026, and $237.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 219.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -679.00 Mn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 89.50 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 35.58 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 38.12 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 31.50 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 12.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 219.00 Mn
Mar 29, 2026 229.00 Mn
Dec 28, 2025 237.00 Mn
Sep 28, 2025 227.00 Mn
Jun 29, 2025 260.00 Mn
Mar 30, 2025 332.00 Mn
Dec 29, 2024 281.00 Mn
Sep 29, 2024 292.00 Mn
Jun 30, 2024 395.00 Mn
Mar 31, 2024 364.00 Mn
Dec 31, 2023 363.00 Mn
Oct 1, 2023 374.00 Mn
Jul 2, 2023 326.00 Mn
Apr 2, 2023 198.00 Mn
Jan 1, 2023 450.00 Mn
Oct 2, 2022 150.00 Mn
Jul 3, 2022 64.00 Mn
Apr 3, 2022 22.00 Mn
Oct 3, 2021 13.00 Mn
Jul 4, 2021 12.00 Mn